Clinical Trial Update: High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on high-dose fluconazole for cryptococcal meningitis in HIV patients; phases 1/2 completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cryptococcal Meningitis
• HIV Infections

Drugs mentioned

• Fluconazole (Fluconazole)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Cryptococcal Meningitis, HIV Infections | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-03-12